Tianjin Century Kangtai Biomedical Engineering
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- Undisclosed
Investors
- 5
About Tianjin Century Kangtai Biomedical Engineering
Established in 2008 and based in Tianjin, China, Tianjin Century Kangtai Biomedical Engineering operates as a medical device manufacturer that provides eye health solutions., Ltd. is a wholly-owned subsidiary of the company. The company is headquartered in Tianjin and its plant covers an area of 5,000 square meters. It has many awards, such as "State-level high-tech enterprises" and "State-level and Tianjin science and technology-based small and medium-sized enterprises". In July 2023, the company's product "pre-assembled hydrophobic aspheric IOL" was approved. The company uses collagen-based biomaterials to develop ophthalmic medical devices. Its products are divided into two series, which include the ophthalmic material intraocular lens (IOL) series and the biomaterial collagen sponge series, such as disposable foldable IOL infuser, hydrophilic spherical foldable IOL and ocular fixation ring. The company will launch a diffractive multifocal IOL in 2024.
Who invested in Tianjin Century Kangtai Biomedical Engineering
5 investors across 1 round
See all investors in Tianjin Century Kangtai Biomedical Engineering
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 20, 2023
Amount
Undisclosed
Investors
Questions about Tianjin Century Kangtai Biomedical Engineering
Who invested in Tianjin Century Kangtai Biomedical Engineering?
Tianjin Century Kangtai Biomedical Engineering has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tianjin Century Kangtai Biomedical Engineering raised?
Tianjin Century Kangtai Biomedical Engineering has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tianjin Century Kangtai Biomedical Engineering last raise money?
Tianjin Century Kangtai Biomedical Engineering's most recent round on record is a Series B, in Sep 2023.
What does Tianjin Century Kangtai Biomedical Engineering do?
Established in 2008 and based in Tianjin, China, Tianjin Century Kangtai Biomedical Engineering operates as a medical device manufacturer that provides eye health solutions.
Where is Tianjin Century Kangtai Biomedical Engineering headquartered?
Tianjin Century Kangtai Biomedical Engineering is headquartered in Tianjin, China.
Which VCs invest in companies like Tianjin Century Kangtai Biomedical Engineering?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Tianjin Century Kangtai Biomedical Engineering's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Tianjin Century Kangtai Biomedical Engineering? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.